NCT03883802View on ClinicalTrials.gov

Foxy-5 as Neo-Adjuvant Therapy in Subjects With Wnt-5a Low Colon Cancer

PHASE2UnknownINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

April 12, 2019

Primary Completion Date

December 14, 2024

Study Completion Date

December 14, 2024

Conditions
Colon Cancer
Interventions
DRUG

Foxy-5

Lyophilized powder for solution for intravenous infusion

DRUG

FOLFOX regimen

6 months treatment regimen

PROCEDURE

Tumour resection (colon cancer surgery)

Surgical removal of patients colon cancer

Trial Locations (1)

46010

Instituto de Investigación Sanitaria INCLIVA, Valencia

Sponsors

Collaborators (1)

BioVica AB
All Listed Sponsors
collaborator

SMS-Oncology BV

UNKNOWN

collaborator

SAGA diagnostics AB

UNKNOWN

collaborator

Unilabs A/S

UNKNOWN

collaborator

BioVica AB

UNKNOWN

collaborator

Institut Català d'Oncologia

OTHER

lead

WntResearch AB

INDUSTRY

NCT03883802 - Foxy-5 as Neo-Adjuvant Therapy in Subjects With Wnt-5a Low Colon Cancer | Biotech Hunter | Biotech Hunter